NDAURETHRALSOLUTION
Approved
Aug 1955
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 26m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CYSTOGRAFIN (diatrizoate meglumine) is a contrast agent administered via urethral route as a solution for radiographic imaging of the urinary tract. It belongs to the iodinated contrast media class and is used to visualize urological structures during cystography and related diagnostic procedures. The drug has been approved since 1955 and remains a legacy diagnostic agent in radiology.
LOE Approaching
As a legacy diagnostic product approaching loss of exclusivity, the commercial team is likely small and focused on maintaining niche market share in specialized urology and radiology settings.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CYSTOGRAFIN offers limited career growth potential given its mature lifecycle and approaching loss of exclusivity. Roles are primarily maintenance-oriented, focused on defending market share and managing clinical relationships in specialty radiology and urology segments rather than driving innovation or expansion.
Medical Science Liaison (MSL)Product Manager
Worked on CYSTOGRAFIN at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.